Beyond Steroids: Topical Dermatological Efficacy and Patient-Centric Perspectives

home / frontline-forum / beyond-steroids-topical-dermatological-efficacy-and-patient-centric-perspectives

Beyond Steroids: Topical Dermatological Efficacy and Patient-Centric Perspectives

Experts in the management of skin conditions recap key insight from a roundtable discussion delving into unmet needs in non-steroidal topical treatment for atopic dermatitis. They discuss the safety, efficacy, and rapid itch relief of topical ruxolitinib, and offer insights on counseling patients about its black box warning. Furthermore, the program explores perceptions of limited treatment access and how to address this issue.

Articles

Discovering Dermatology Times: May 2024 Enhancing Atopic Dermatitis Care Supplement

May 29th 2024

Learn more about the in-depth topics covered in the May 2024 supplement of Dermatology Times.

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

May 21st 2024

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.

Videos

Enhancing Accessibility: Ruxolitinib Cream and Improved Patient Access

April 19th 2024

Lisa Swanson, MD, FAAD, sheds light on the enhanced accessibility of ruxolitinib cream, highlighting its improved availability for patients in need.

Ruxolitinib Cream vs. Corticosteroids in AD: Commentary on Location-Specific Safety and Continuous Use Potential

April 19th 2024

Brad Glick, DO, MPH, FAAD, notes the absence of location restrictions with topical ruxolitinib cream, distinguishing it from topical corticosteroids. The panel discusses the cyclic pattern of steroid use and the potential of ruxolitinib cream as a continuous treatment option.

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777